Orchard achieves $1.2B valuation with $200M IPO

Orchard Therapeutics Ltd. (NASDAQ:ORTX) raised $200 million Wednesday in an IPO that priced at the bottom of its proposed range, but sold more ADSs than proposed. The IPO price values

Read the full 306 word article

How to gain access

Continue reading with a
two-week free trial.